Our initial focus areas include contraception fertility and sexual and vaginal health|SABRINA MARTUCCI JOHNSON,President,Dare Bioscience Inc 00:10:00
Ms. Johnson founded Daré Bioscience Operations in 2015 and has served as President, CEO and a member of the Board of Directors since its inception and following its business combination with Cerulean Pharma in July 2017, when the Company was renamed Daré Bioscience. Ms. Johnson is a life sciences executive committed to advancing improvements in women’s healthcare.